Results 11 to 20 of about 187,751 (309)
Commercial Payors More Likely to Reimburse Unlisted Hip Arthroscopy Procedures Compared With Managed Care but With Similar Overall Dollar Amount. [PDF]
Arthrosc Sports Med RehabilPurpose To compare the reimbursement practices of public managed care (MC) insurance versus private commercial insurance (COM) for hip arthroscopy using the current procedural terminology (CPT) code 29999. Methods The CPT codes and corresponding reimbursements of hip arthroscopies that employed code 29999 performed from January 2020 to December 2024 in
Neufeld EV +4 more
europepmc +2 more sources
Primary Care Reimbursement Service Statistical Analysis of Claims and Payments 2021 [PDF]
, 2022 The Primary Care Reimbursement Service (PCRS) is responsible for reimbursing GPs, Dentists, Pharmacists, Optometrists/Ophthalmologists and other contractors who provide free or reduced-cost services to the public across a range of primary care schemes ...
Primary Care Reimbursement Service (PCRS)
core
Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
Journal of Market Access & Health Policy, 2017 Introduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016.
Krzysztof Lach +3 more
doaj +1 more source
Access to precision medicine in Thailand: a comparative study [PDF]
Journal of Health Research, 2022 Purpose – This study explored health insurance coverage of genetic testing and potential factors associated with precision medicine (PM) reimbursement in Thailand. Design/methodology/approach – The study employed a targeted review method.
Nisita Jirawutkornkul +2 more
doaj +1 more source
Waiting for reimbursement [PDF]
Science, 2019 It has been an exciting and productive conference. As a fifth-year Ph.D. student, I am less nervous when I present my work than I used to be, and I finally feel I fit in as a scholar. But when my abstract was accepted in the fall, I had to consider something completely unrelated to my science: whether I could afford to go.
openaire +2 more sources
Cost Effectiveness and Resource Allocation, 2019 Background To estimate the incremental cost-effectiveness ratio (ICER) of the use of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injections (MDI) therapy in adult patients with type 1 diabetes (T1D) at the Mexican ...
Svetlana V. Doubova +10 more
doaj +1 more source
Comparison of Cardiovascular Medicines Prices in Four European Countries
Frontiers in Public Health, 2020 The aim of the current study was to compare pricing methodologies at the manufacturer, wholesale, and retail levels, and to estimate the price differences of AT1-receptor blockers (sartans), Angiotensin-converting enzyme (ACE)—inhibitors, and their fixed-
Zornitsa Mitkova +8 more
doaj +1 more source
GMS German Medical Science, 2022 Background: Horizon scanning aims to systematically identify upcoming health technologies and thus allows policy-makers to be better prepared for the entry of new medicines with possibly high price tags into the national health system.
Vogler, Sabine
doaj +1 more source
A comparative study of orphan drug prices in Europe
Journal of Market Access & Health Policy, 2017 Background and Objective: This study assessed price differences by comparing annual treatment costs of similarly available orphan drugs in France, Germany, Italy, Norway, Spain, Sweden, and UK.
Katherine Eve Young +3 more
doaj +1 more source
Frontiers in Public Health, 2018 BackgroundPolicy makers face a lot of challenges in the process of drug reimbursement decision-making, especially in the context of entering the market of more and more innovative medicinal products (MPs).
Maria Kamusheva +6 more
doaj +1 more source